COVID-19
While I’m all for a bit of triumphalism when some component of conventional publication vis-à-vis scientific research – like pre-publication anonymous peer review – fails, and fails publicly, I spotted an article in The Conversation earlier today that I thought crossed a line (and not in the way you think). In
COVID-19
I was slightly disappointed to read a report in the New York Times this morning. Entitled ‘Two Huge COVID-19 Studies Are Retracted After Scientists Sound Alarms’, it discussed the implications of two large studies of COVID-19 recently being retracted by two leading medical journals they were published in, the New
data sharing
Twitter outraged like only Twitter could on January 22 over a strange editorial that appeared in the prestigious New England Journal of Medicine, calling for medical researchers to not make their research data public. The call comes at a time when the scientific publishing zeitgeist is slowly but surely shifting
